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NeuN is an antigen detected in the nucleus of neurons in a wide range of vertebrates and so it is
widely used as a tool for detecting neuronal cells. NeuN has been recently identiﬁed as Fox-3, a
new member of the Fox-1 gene family of splicing factors. The predominant localization of NeuN/
Fox-3 to neuronal nuclei and its role in splicing pose the question of the nuclear compartmentali-
zation of such a protein. Here we provide evidence that NeuN/Fox-3 is an intrinsic component of
the neuronal nuclear matrix and a reliable marker of nuclear speckles in neurons.
Structured summary:
MINT-7890176: Fox-3 (uniprotkb:B7ZC13) and Splicing factor SC35 (uniprotkb:Q6PDU1) colocalize
(MI:0403) by ﬂuorescence microscopy (MI:0416)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction that the so-called nuclear speckles enriched in splicing factors forNeuN (neuronal nuclei) is an antigen that is consistently de-
tected by the corresponding monoclonal antibody anti-NeuN in
the nucleus of most types of neurons [1,2] in a wide range of ver-
tebrates including mammals, birds and amphibians. Therefore,
anti-NeuN is widely used as a tool for detecting neuronal cells from
the central and peripheral nervous systems. Recently it has been
clariﬁed the actual identity of the NeuN protein that was identiﬁed
as Fox-3, a newmember of the Fox-1 gene family of splicing factors
that functions as regulator of splicing [3]. The predominant locali-
zation of NeuN/Fox-3 to neuronal nuclei and its role in splicing of
primary transcripts pose the question of the nuclear compartmen-
talization of such a protein. The nuclear matrix (NM) has been
operationally deﬁned as the nuclear substructure that results from
extracting cells in presence of high-salt, non-ionic detergents and
DNase [4–6]. The speciﬁc composition of the NM is still a matter
of debate as some four hundred proteins have been associated with
this substructure yet about 50% of such proteins appear to be com-
ponents of the internal NM whereas others exhibit a cell-cycle-
dependent association with the substructure [7]. However, at least
in mammals, there is evidence for a limited set of proteins common
to the NM of all cell types [8] whereas others are cell-type-speciﬁc
[9]. There is varied evidence that fundamental processes of nuclear
physiology, such as replication, transcription and splicing of pri-
mary transcripts, occur at macromolecular complexes organized
upon the NM [10–12]. Moreover, numerous observations indicatechemical Societies. Published by E
ail.com (A. Aranda-Anzaldo).pre-messenger RNA interact with the NM [13–16]. Here we pro-
vide evidence that NeuN/Fox-3 is an intrinsic component of the
neuronal NM and a reliable marker of nuclear speckles in neurons.
2. Materials and methods
2.1. Animals
Male Wistar rats weighing 200–250 g were used for isolation of
rat neuronal nuclei. All animals were used in accordance with the
ofﬁcial Mexican norm for production, care and use of laboratory
animals (NOM-062-ZOO-1999).
2.2. Neuronal nuclei isolation
Neuronal nuclei from cerebral cortex of young-adult rats were
isolated as described [17] with slight modiﬁcations. The cerebral
cortex was dissected and then homogenized with 1 ml of 2.0 M su-
crose (1 mM MgCl2 + 0.25 mM PMSF). The homogenate was trans-
ferred to a tube containing 5 ml of 2.0 M sucrose and spun at 4 C
for 60 min at 49 000g. The pellet was washed with 10 ml of
0.32 M sucrose (1 mM MgCl2 + 0.25 mM PMSF) and spun for
5 min at 1500g. The ﬁnal pellet was resuspended in 1 ml of
0.32 M sucrose.
2.3. Preparation of nuclear substructures
1  106 nuclei from cerebral cortex cells were suspended in
0.5 ml of TM-2 buffer (2 mM MgCl2; 0.5 mM PMSF; 10 mM Trislsevier B.V. All rights reserved.
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and allowed to dry for 1 h at room temperature. Nuclear substruc-
tures were obtained as previously described [18]. Brieﬂy, for nucle-
oid preparation in situ the dried sample was treated with 500 ll of
lysis buffer (2.6 M NaCl; 1.3 mM EDTA; 2.6 mM Tris; 0.6% Triton X-
100; pH 8.0) for 10 min at 4 C, and washed in PBS without Ca2+
and Mg2+ (PBS-A). For obtaining the DNA-depleted NM the dried
nucleoids were treated in situ with 500 ll of DNase I (7 U/ml) at
37 C for 3 h under continuous shaking. The slides were washed
with PBS-A (5 min) and next with ultra-pure water at room tem-
perature. For obtaining the DNA–RNA-depleted NM in situ the
samples were digested with 300 ll of RNase A (at 200 lg/ml;
86 U kunitz/mg) for 1 h at 37 C and then washed with PBS-A.
2.4. Immunoﬂuorescence
For immunoﬂuorescence all kind of samples were ﬁxed for
15 min with 4% paraformaldehyde in 0.1 M NaH2PO4 + 0.1 M
Na2HPO4, pH 7.4. Sample slides were treated either with monoclo-
nal mouse anti-NeuN (1:500, Chemicon), rabbit polyclonal anti-
Lamin B1 (1:2000, Abcam), goat polyclonal anti-SC35-D-18
(1:100, Santa Cruz Biotech.), goat polyclonal anti-SRm160-K-15
(1:100, Santa Cruz Biotech.) in PBS-A with 10 ll of 10% milk and
1.5 ll Tween 20, in a humidiﬁed chamber 4 h at 4 C. The anti-
NeuN treated samples were further treated with Alexa ﬂuor 568
(red, 1:2000) in PBS-A in a humidiﬁed chamber for 1 h at 4 C.
Anti-Lamin B1 treated samples were further treated with biotinyl-
ated goat anti-rabbit IgG (1:500, Vector) in PBS-A with 10 ll of 10%
milk in a humidiﬁed chamber for 1 h at 4 C and further treated
with ﬂuorescein-avidin (1:500, Vector) for 30 min at 4 C. The
anti-SC35 and anti-SRm160 treated samples were further treated
with biotinylated horse anti-goat IgG (1:1000, Vector) in PBS-A
with 10 ll of 10% milk in a humidiﬁed chamber for 1 h at 4 C
and then further treated with ﬂuorescein-avidin (1:1000, Vector)
for 30 min at 4 C. The slides were mounted with VectaShield. Sam-
ples were observed in an Olympus BX60 ﬂuorescence microscope.
Analysis of co-localization of the speciﬁc ﬂuorescent signals was
done using the Image-Pro-Plus Analysis System.
2.5. Western blot
Total protein extraction and quantiﬁcationwas done by standard
procedures. Protein samples were subjected to standard PAGE in 4–
10% discontinuous gels. The proteins were electro-transferred to a
nitrocellulose membrane Hybond-ECL (GE Healthcare). The mem-
brane was incubated in TBST buffer (10 mM Tris, 150 mM NaCl,
0.05% Tween, pH 8.0) with 10% milk for 2 h at room temperature.
Next the membrane was treated with mouse anti-NeuN (1:5000)
or mouse anti-Actin (1:40 000; Millipore) in TBST buffer with 5%
milk for 1 h. After three washes with TBST the membrane was incu-
bated with biotinylated horse anti-mouse, rat-adsorbed, IgG
(1:3000, Vector) in TBST with 5% milk for 1 h. Then treated with
the pre-mixed A + B reagents from VectaStain elite ABC kit (Vector)
for 30 min. The signal was developed with Amersham ECL reagent
(GE Healthcare) for 2 min and captured on ECL Hyperﬁlm.Fig. 1. Microscopic characterization of neuronal nuclear substructures. Represen-
tative phase-contrast micrographs of: neuronal nuclei (A), nucleoids (D), DNA-
depleted NM (G) and DNA–RNA-depleted NM (J). The samples were treated with
ethidium bromide (EB) at a ﬁnal concentration 80 lg/ml for staining DNA/RNA.
Fluorescent micrographs were obtained after differential sample-exposures: B and
E = 10 ms; C, F, H and K = 50 ms; I and L = 200 ms. Notice the EB-induced DNA halo
surrounding the NM in the nucleoid preparation (F). The faint internal ﬂuorescence
in the DNA-depleted NM sample is from the residual nucleoli and the internal
ﬁbrogranular RNP network (H and I). EB-ﬂuorescence is not detectable in the DNA–
RNA-depleted NM even after a 200 ms exposure (K and L). Bar = 10 lm.3. Results
3.1. Differential identiﬁcation of nuclei and nucleoids from neurons
In nuclei and nucleoid preparations obtained from cells of the
rat cerebral cortex the neuron-speciﬁc nuclei and nucleoids were
detected by indirect immunoﬂuorescence using a mAb against
the neuron-speciﬁc nuclear protein NeuN. The percentage of
neuron-speciﬁc nuclei and nucleoids was estimated by countingpositive-stained nuclei/nucleoids against non-stained. In fresh
preparations of nuclei the contamination by NeuN-negative nuclei
(glial-cell nuclei) was <27%. However, after extracting the rather
mixed nuclei for obtaining nucleoids, the contamination by
NeuN-negative nucleoids fell to <8%, indicating that most glial-cell
nuclei were unable to withstand the nucleoid extraction proce-
dure. Hence the resulting nucleoid preparations were highly en-
riched (>92%) in neuron-speciﬁc nucleoids and so it is possible to
use the isolated nuclei from cerebral cortex for obtaining NM prep-
arations that basically consist of neuron-derived substructures.
3.2. Characterization of nuclear substructures from rat neuronal nuclei
Nuclei (Fig. 1A) were extracted with high-salt and non-ionic
detergent for obtaining nuclear substructures known as nucleoids
(Fig. 1D) in which the naked nuclear DNA, organized in supercoiled
loops, remains attached to the NM [18,19]. However, treatment of
nucleoids with the DNA-intercalating agent ethidium bromide (EB)
causes unwinding of the supercoiled DNA loops [18,20], since the
EB acts as a molecular lever leading to the formation of a ﬂuores-
cent DNA halo that surrounds the NM (Fig. 1E and F). Treatment
of nucleoids with DNase I leads to disappearance of the ﬂuorescent
DNA halo remaining a faint ﬂuorescence resulting from the stain-
ing of nucleoli and internal ribonucleoprotein within the boundary
of the NM (Fig. 1H and I). Indeed, it is known that heterogeneous
nuclear ribonucleoprotein (hnRNP) constitutes a signiﬁcant com-
ponent of the NM internal ﬁbrogranular network [4,21]. Further
treatment of DNA-depleted NM preparations with RNase A leads
to disappearance of any residual ﬂuorescence after exposure to
EB (Fig. 1K and L).
Fig. 2. Detection of NeuN/Fox-3 in neuronal nuclear substructures. Phase-contrast
micrographs of: nuclei (A), nucleoids (D), DNA-depleted NM (G), DNA–RNA-
depleted NM (J). NeuN-speciﬁc indirect immunoﬂuorescence was detected at
differential sample-exposures: B and E = 100 ms; H and K = 50 ms. Notice that
sample exposure had to be reduced in the NM preparations (H and K) so as to avoid
saturation, indicating that removal of both the nuclear membrane and nuclear DNA
signiﬁcantly reduced the quenching of the ﬂuorescent signal resulting from NM-
bound NeuN. The corresponding negative controls in which the primary anti-NeuN
mAb was excluded (C, F, I and L) conﬁrm the immunoﬂuorescence speciﬁcity.
Bar = 10 lm.
Fig. 3. Comparative immunoﬂuorescent patterns for NeuN/Fox-3, lamin B1, SC35 and SRm
andM) were immunostained by speciﬁc indirect immunoﬂuorescence for NeuN (B, F, J an
(O). Notice the signiﬁcant presence of NeuN/Fox-3 in peripherally-located NM-bound spe
rim that do not co-localizes with NeuN/Fox-3 (D and H). The immuno-staining pattern
localization coefﬁcient >0.99) with those for SC35 (L) and SRm160 (P). Bar = 5 lm.
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Neuronal nuclei and the three different kinds of nuclear sub-
structures: nucleoids, DNA-depleted NM and DNA–RNA-depleted
NM, were subjected to indirect immunoﬂuorescence with anti-
NeuN. The results show that NeuN is present in the nucleoplasm
since there is a reduced immuno-staining for NeuN in neuronal
nucleoids when compared with that in the original neuronal nuclei
(Fig. 2B and E). However, nucleoids contain about 10% of the total
nuclear protein [22] and yet there is a signiﬁcant immuno-staining
for NeuN in such substructures. The staining is shared between a
few large speckles and a diffuse immuno-staining within the
boundary of the nucleoid, suggesting that some portion of NeuN
may interact with the naked loop DNA and/or the internal network
of ribonucleoprotein (Fig. 2E). When DNA is removed by treatment
with DNase I the resulting NM shows signiﬁcant staining for NeuN
that is concentrated in a few large speckles although there it re-
mains some diffuse staining in the internal NM (Fig. 2H). However,
after removing the internal ribonucleoprotein network by treat-
ment with RNase A, the sharp NeuN staining concentrates in
speckles, which in some preparations appear to be peripherally-lo-
cated and somehow fused to each other (Fig. 2K).
Lamin B provides structural support to the nuclear membrane
and is a major component of the peripheral NM [23] deﬁning a
smooth boundary for the whole neuronal nucleus and the neuronal
NM preparations (Fig. 3). Comparison of the immunoﬂuorescent
staining patterns for both NeuN and lamin B in the neuronal NM
preparations, conﬁrms that a signiﬁcant portion of NeuN is concen-
trated in speckles that are preferentially located within the periph-
ery of the NM (Fig. 3B and F). The serine/arginine-rich splicing
factor SC35 and the serine/arginine-rich splicing co-activator
SRm160 are two reliable markers of nuclear speckles also known
to be associated with the NM [15,24], the immunoﬂuorescent160. (NM) DNA-depleted NM (A) and (NM + RNase A) DNA–RNA-depleted NM (E, I
d N), lamin B1 (C and G), splicing factor SC35 (K) and co-activator of splicing SRm160
ckles (B and F) while lamin B1 immunoﬂuorescence is restricted to a smooth stained
for NeuN/Fox-3 in DNA–RNA-depleted neuronal NM matches almost perfectly (co-
Fig. 4. Detection of NeuN/Fox-3 by Western blot. Similar quantities (15 lg) of total
extracted proteins from rat peripheral sciatic nerve (Ne), cerebral cortex (C),
neuronal nuclei (N), neuronal nucleoids (Nu), neuronal DNA-depleted NM (MN),
neuronal DNA–RNA-depleted NM (NM + RNase A) and spleen (S), were subjected to
detection of NeuN/Fox-3 with speciﬁc anti-NeuN mAb. Notice the presence of both
NeuN/Fox-3 isoforms (46–48 kDa) in all samples except peripheral nerve and
spleen (negative controls). Both NeuN/Fox-3 isoforms are readily detected in the
ultimate DNA–RNA-depleted NM. b-Actin (42 kDa) was detected in all lanes as
control for whole protein loading.
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match almost perfectly (co-localization coefﬁcient >0.99) in neuro-
nal NM preparations (Fig. 3L and P).
3.4. NeuN/Fox-3 protein in neuronal nuclear substructures
Western blot analysis of the different nuclear substructure
preparations (Fig. 4) conﬁrms that some portion of NeuN is present
in the nucleoplasm and that a further portion may be associated to
the internal ribonucleoprotein network as judged by comparing
the corresponding NeuN signals in nuclei, nucleoid and NM prepa-
rations. However, a sizeable portion of NeuN remains in DNA–
RNA-depleted NM preparations despite the fact that such prepara-
tions are known to contain only some 10% of total nuclear protein,
less than 1% total DNA and less than 5% total RNA [22], strongly
suggesting that NeuN is an intrinsic component of the NM of
neurons.
4. Discussion
The antigen NeuN recently identiﬁed as the Fox-3 splicing fac-
tor is a protein speciﬁcally expressed in most types of neurons,
thus it is a reliable marker of neuronal identity. Fox-3 is a regulator
of splicing that activates neural cell-speciﬁc splicing [3]. Splicing
factors are known to be enriched in subnuclear structures known
as speckles that vary in size and shape. Such speckles show a dy-
namic behavior since both their protein and ribonucleoprotein
components cycle continuously between the speckles and other
nuclear locations that include active transcription sites [25]. Yet
the speckles are known to interact directly with the NM
[4,15,16]. The observed intranuclear compartmentalization of
NeuN/Fox-3 is consistent with its role as a splicing factor thus
being present in the nucleoplasm, where it may interact with
hnRNP, as well as being concentrated in discrete speckles bound
to the NM (Figs. 2–4). Thus, NeuN/Fox-3 is likely to be shuttling be-
tween the nucleoplasm and the NM. Yet there is always a sizeable
portion of the splicing factor that is consistently bound to the ulti-
mate NM fraction of neurons, despite the rather harsh procedure
for isolating such a substructure that removes some 90% of the ori-
ginal nuclear protein and almost all DNA and RNA [18,22]. There-
fore, NeuN/Fox-3 may be regarded as an intrinsic component of
the neuronal NM. Topoisomerase II alpha is also an intrinsic NM
protein that nevertheless shuttles continuously between the NM
and the nucleoplasm. This enzyme has been consistently isolated
in the ultimate NM fraction of most cell types [26,27] yet it ex-
changes continuously with the soluble pool of nuclear proteins[28]. Such a behavior is not in conﬂict with the current concept
of the NM as both a dynamic structure and a nuclear compartment
in which most of the proteins are not ﬁrmly restrained but contin-
uously shuttle between the NM and the nucleoplasm [6]. Hence
the NM is a structured milieu in which concentrated nuclear pro-
teins statistically increase their probabilities for interaction, thus
facilitating the formation of macromolecular complexes organized
on the NM that participate in the fundamental processes of nuclear
physiology such as replication, transcription and splicing. Indeed,
SRm160 a co-activator of splicing present in nuclear speckles con-
tains structural motifs that target the protein to NM sites at splic-
ing speckled domains [15]. Such a protein forms a stable complex
with a 300 kDa NM-antigen [29]. Thus it is remarkable that NeuN
location in neuronal NM preparations matches almost perfectly the
distribution of SRm160 in the same preparations (Fig. 3P). There-
fore NeuN/Fox-3 is a reliable marker for speckles in neuronal cells.
Moreover, the fact that a regulator of splicing such as NeuN/Fox-3
is concentrated in speckles bound to the ultimate neuronal NM is
consistent with the fact that the brain is the organ where alterna-
tive splicing occurs more frequently [30].
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